in our DNA. This not only applies to our products but to the partnership with our customers as well. We look forward to demonstrate this when working with you.
profiles of complex sera, cross-reactivity of monoclonal antibodies, protein-protein interaction pairs, DNA/RNA binding proteins, etc.
of therapeutic antibodies are made using recombinant DNA technology, which has enabled the engineering of specific functions and the reduction or elimination
to support isothermal amplification of DNA and RNA. The market pull for this venture came from the growing demands around the world for field testing,
IFT, RC-IFT). In the area of molecular diagnostics, EUROIMMUN develops multiparametric DNA microarrays for the identification of disease-associated gene